A total of 16,755 vaccinators participated in the vaccination process across India, the ministry added. Not a single case of hospitalisation post-vaccine administration has been reported yet

In the first phase of the vaccination drive over 3 crores frontline healthcare workers are expected to be given the vaccine. They will receive either Covaxin or Covishield COVID-19 vaccines which were approved for emergency use earlier by the country's drug regulators

Coronavirus vaccination drive: Covaxin has asked its recipients to sign a consent form. The form also states that in case of adverse effects, the recipient would be compensated

In the consent form for getting Covaxin vaccine, recipients have been promised that in case of any adverse situation following the administration of the vaccine and if it is determined that the vaccine was the cause then the recipients will be given compensation and medical

Coronavirus vaccination drive: It brings me great pride that Covishield is part of this historic effort, said Serum Institute CEO Adar Poonawalla

Ten of these states have already received 20,000 doses of Covaxin, while Assam has so far got 12,000 doses

COVID-19 vaccine memes: Keeping in mind India's love for food, netizens have come up with funny ways -- likely to be least resisted by Indians -- to vaccinate the country

Key to the success of the pan-India COVID-19 vaccination drive, scheduled to be launched by PM Narendra Modi on January 16, will be the cybersecurity framework India has readied, experts say

Company shall be liable for all adversities as per CDSCO/Drugs and Cosmetics Act/DCGI policy/approval, says government's purchase order with vaccine makers

As of now, the pre-condition for any vaccine to be implemented in India is that you have to do a bridging trial, said Niti Aayog member VK Paul who also heads National Expert Group On Vaccine Administration for COVID-19 (NEGVAC)

The pre-prints or preliminary reports of research work related to Covaxin, which are yet to be peer-reviewed are already posted on pre-print servers like bioRxiv, medRxiv and Research Square

Coronavirus vaccination drive: Serum Institute will provide the coronavirus vaccine at Rs 200 per dose, while Bharat Biotech would provide Covaxin at Rs 206 per dose to the government

Centre has placed orders in advanced commitments for over 6 crore doses of COVID vaccine from SII and Bharat Biotech for inoculating 3 crore healthcare and frontline workers in first vaccination phase that starts January 16

A team from Precisa Medicamentos visited the Bharat Biotech's Hyderabad facility last week to discuss potential export possibilities of Covaxin with Chairman Dr Krishna Ella on the January 7-8

Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine

The two vaccines - Covishield and Covaxin - have received regulatory approval after extensive studies. The Covishield  vaccine has already been rolled out in the UK

The first order of 1.1 crore doses will be worth Rs 231 crore, while the total amount, including the commitment for 4.5 crore doses, with the total estimated to reach Rs 1,176 crore at current rates

Pfizer is yet to submit additional data sought by India authorities regarding its COVID-19 vaccine for granting emergency use approval to it; the company has missed last three SEC meetings too

Ahead of the nationwide roll-out of COVID-19 vaccine, states have made all necessary preparations, including identifying vaccination sites and registration of healthcare and other frontline workers

This will be the first interaction between the Prime Minister and the chief ministers of all states after the Drugs Controller General of India (DCGI) granted emergency use authorisation to Covishield and Covaxin